Literature DB >> 28597909

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).

Beata Kos-Kudła1, Jolanta Blicharz-Dorniak, Janusz Strzelczyk, Agata Bałdys-Waligórska, Tomasz Bednarczuk, Marek Bolanowski, Agnieszka Boratyn-Nowicka, Małgorzata Borowska, Andrzej Cichocki, Jarosław B Ćwikła, Massimo Falconi, Wanda Foltyn, Daria Handkiewicz-Junak, Alicja Hubalewska-Dydejczyk, Barbara Jarząb, Roman Junik, Dariusz Kajdaniuk, Grzegorz Kamiński, Agnieszka Kolasińska-Ćwikła, Aldona Kowalska, Robert Król, Leszek Królicki, Maciej Krzakowski, Jolanta Kunikowska, Katarzyna Kuśnierz, Paweł Lampe, Dariusz Lange, Anna Lewczuk-Myślicka, Andrzej Lewiński, Michał Lipiński, Magdalena Londzin-Olesik, Bogdan Marek, Anna Nasierowska-Guttmejer, Sergiusz Nawrocki, Ewa Nowakowska-Duława, Joanna Pilch-Kowalczyk, Violetta Rosiek, Marek Ruchała, Lucyna Siemińska, Anna Sowa-Staszczak, Teresa Starzyńska, Katarzyna Steinhof-Radwańska, Krzysztof Sworczak, Anhelli Syrenicz, Andrzej Szawłowski, Marek Szczepkowski, Ewa Wachuła, Wojciech Zajęcki, Anna Zemczak, Wojciech Zgliczyński, Krzysztof Zieniewicz.   

Abstract

Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NEN), the published results of new randomised clinical trials, and the new guidelines issued by the European Neuroendocrine Tumour Society (ENETS) have led the Polish Network of Neuroendocrine Tumours to update the 2013 guidelines regarding management of these neoplasms. We present the general recommendations for the management of NENs, developed by experts during the Third Round Table Conference - Diagnostics and therapy of gastro-entero-pancreatic neuroendocrine neoplasms: Polish recommendations in view of current European recommenda-tions, which took place in December 2016 in Żelechów near Warsaw. Drawing from the extensive experience of centres dealing with this type of neoplasms, we hope that we have managed to develop the optimal management system, applying the most recent achievements in the field of medicine, for these patients, and that it can be implemented effectively in Poland. These management guidelines have been arranged in the following order: gastric and duodenal NENs (including gastrinoma); pancreatic NENs; NENs of the small intestine and appendix, and colorectal NENs.

Entities:  

Keywords:  diagnostics; gastro-entero-pancreatic neuroendocrine neoplasms; therapy

Mesh:

Year:  2017        PMID: 28597909     DOI: 10.5603/EP.2017.0015

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  19 in total

1.  Intrapancreatic accessory spleen: an enigmatic entity.

Authors:  Namita Chavan; Gunjan Shailesh Desai; Chandralekha Tampi; Prasad Wagle
Journal:  BMJ Case Rep       Date:  2019-03-20

2.  Endoscopic ultrasonography is useful in the diagnosis and treatment of rectal neuroendocrine neoplasms: a case series.

Authors:  Qing Gu; Yi-Ming Lin; Li Cen; Min Xu; Hong-Zhang Li; Xian-Chu Lin; Chao Lu
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

3.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

4.  NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.

Authors:  Anna Malczewska; Kjell Oberg; Beata Kos-Kudla
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

5.  Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.

Authors:  Teresa Starzyńska; Jakub Karczmarski; Agnieszka Paziewska; Maria Kulecka; Katarzyna Kuśnierz; Natalia Żeber-Lubecka; Filip Ambrożkiewicz; Michał Mikula; Beata Kos-Kudła; Jerzy Ostrowski
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

6.  The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.

Authors:  A Malczewska; A Procner; A Walter; K Kusnierz; W Zajecki; H Aslanian; B Kos-Kudla
Journal:  BMC Gastroenterol       Date:  2020-07-23       Impact factor: 3.067

Review 7.  The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.

Authors:  Jakub Pobłocki; Anna Jasińska; Anhelli Syrenicz; Elżbieta Andrysiak-Mamos; Małgorzata Szczuko
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

Review 8.  Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors.

Authors:  Paola Di Giacinto; Francesca Rota; Laura Rizza; Davide Campana; Andrea Isidori; Andrea Lania; Andrea Lenzi; Paolo Zuppi; Roberto Baldelli
Journal:  Int J Endocrinol       Date:  2018-07-02       Impact factor: 3.257

9.  Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience.

Authors:  Jolanta Kunikowska; Anna Zemczak; Maciej Kołodziej; Paweł Gut; Izabela Łoń; Dariusz Pawlak; Renata Mikołajczak; Grzegorz Kamiński; Marek Ruchała; Beata Kos-Kudła; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-24       Impact factor: 9.236

10.  Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine.

Authors:  Małgorzata Fuksiewicz; Maria Kowalska; Agnieszka Kolasińska-Ćwikła; Jarosław B Ćwikła; Łukasz Sawicki; Katarzyna Roszkowska-Purska; Joanna Drygiel; Beata Kotowicz
Journal:  Endocr Connect       Date:  2018-05-03       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.